Schuh Michael J, Garcia Susan
Mayo Clinic Florida.
Innov Pharm. 2024 May 31;15(2). doi: 10.24926/iip.v15i2.6168. eCollection 2024.
Polypharmacy and somatic symptom disorder (SSD) are common conditions clinicians see every day in practice. Polypharmacy is easy to identify and causation seems to be straightforward. However, SSD may not be so obvious and may be an underlying cause of the polypharmacy that may be more difficult to identify. Identifying SSD as a potential psychiatric cause for polypharmacy and understanding that adding more medications will not adequately resolve the patient's symptoms is important to prevent polypharmacy from being exacerbated.
多重用药和躯体症状障碍（SSD）是临床医生在日常实践中常见的情况。多重用药很容易识别，其病因似乎一目了然。然而，SSD可能不那么明显，并且可能是多重用药的一个潜在原因，而这可能更难识别。将SSD识别为多重用药的潜在精神科病因，并认识到增加更多药物并不能充分缓解患者症状，对于防止多重用药情况恶化很重要。
